Advertisement

Topics

Austin’s Apollo Endosurgery Responds to FDA Note After Patient Deaths

15:26 EDT 21 Aug 2017 | Xconomy

Austin—Two years after gaining FDA approval to market a minimally invasive gastrointestinal balloon to combat obesity, Apollo Endosurgery (NASDAQ: APEN) is now dealing with fallout from patient deaths following implantations of the device. In a letter to healthcare providers dated Aug. 10, the FDA stated that seven deaths occurred in patients with liquid-filled intragastric balloon […]

Original Article: Austin’s Apollo Endosurgery Responds to FDA Note After Patient Deaths

NEXT ARTICLE

More From BioPortfolio on "Austin’s Apollo Endosurgery Responds to FDA Note After Patient Deaths"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Endocrinology
Diabetes Diabetes Endocrine Obesity Oxycontin Renal Disease Thyroid Disorders Endocrinology is the study of the endocrine glands and the hormones that they secrete (Oxford Medical Dictionary). There are several groups of h...